Based on the SPDR® S&P Pharmaceuticals ETF stock forecast from 0 analysts, the average analyst target price for SPDR® S&P Pharmaceuticals ETF is not available over the next 12 months. SPDR® S&P Pharmaceuticals ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of SPDR® S&P Pharmaceuticals ETF is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, SPDR® S&P Pharmaceuticals ETF’s stock price was USD 42.82. SPDR® S&P Pharmaceuticals ETF’s stock price has changed by +0.42% over the past week, -6.45% over the past month and +0.47% over the last year.
No recent analyst target price found for SPDR® S&P Pharmaceuticals ETF
No recent average analyst rating found for SPDR® S&P Pharmaceuticals ETF
Company Overview SPDR® S&P Pharmaceuticals ETF
N/A
N/A
N/A
N/A
USD
USA
19/06/2006
S&P Pharms Select Industry TR USD
MSCI ACWI NR USD
N/A
Adjusted Closing Price for SPDR® S&P Pharmaceuticals ETF (XPH)
Loading...
Unadjusted Closing Price for SPDR® S&P Pharmaceuticals ETF (XPH)
Loading...
Share Trading Volume for SPDR® S&P Pharmaceuticals ETF Shares
Loading...
Compare Performance of SPDR® S&P Pharmaceuticals ETF Shares
Frequently Asked Questions About SPDR® S&P Pharmaceuticals ETF (XPH) Stock
Stock Target Advisor's fundamental analysis for SPDR® S&P Pharmaceuticals ETF's stock is Very Bearish.
Unfortunately we do not have enough data on XPH's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on XPH's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on XPH's stock to indicate if its overvalued.
The last closing price of XPH's stock was USD 42.82.
Unfortunately we do not currently have any market capitalization data for XPH's stock.
Unfortunately we do not have enough analyst data on XPH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains SPDR® S&P Pharmaceuticals ETF's stock.
Sorry, we do not have any data on the number of employees for SPDR® S&P Pharmaceuticals ETF.
Sorry we do not have any infomation available on SPDR® S&P Pharmaceuticals ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Frequently Asked Questions About SPDR® S&P Pharmaceuticals ETF (XPH) Stock
Stock Target Advisor's fundamental analysis for SPDR® S&P Pharmaceuticals ETF's stock is Very Bearish.
Unfortunately we do not have enough data on XPH's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on XPH's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on XPH's stock to indicate if its overvalued.
The last closing price of XPH's stock was USD 42.82.
Unfortunately we do not currently have any market capitalization data for XPH's stock.
Unfortunately we do not have enough analyst data on XPH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains SPDR® S&P Pharmaceuticals ETF's stock.
Sorry, we do not have any data on the number of employees for SPDR® S&P Pharmaceuticals ETF.
Sorry we do not have any infomation available on SPDR® S&P Pharmaceuticals ETF's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for XPH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
